Dosage forms and co-administration of an opioid agonist and an opioid antagonist

Details for Australian Patent Application No. 2007317788 (hide)

Owner NEKTAR THERAPEUTICS AL, CORPORATION

Inventors Riggs-Sauthier, Jennifer

Agent Griffith Hack

Pub. Number AU-A-2007317788

PCT Pub. Number WO2008/057579

Priority 60/857,610 07.11.06 US

Filing date 7 November 2007

Wipo publication date 15 May 2008

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/057579 Priority application(s): WO2008/057579

25 February 2010 Assignment before Grant

  NEKTAR THERAPEUTICS AL, CORPORATION The application has been assigned to Nektar Therapeutics Assignments before Grant, Section 113

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007317789-Materials and methods for treating and managing angiogenesis-mediated diseases

2007317787-NMR systems for in vivo detection of analytes